Ashton Thomas Private Wealth, LLC Vyne Therapeutics Inc. Transaction History
Ashton Thomas Private Wealth, LLC
- $1.9 Trillion
- Q3 2024
Shares
1 transactions
Others Institutions Holding VYNE
# of Institutions
2Shares Held
36.5KCall Options Held
0Put Options Held
0About VYNE Therapeutics Inc.
- Ticker VYNE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,005,600
- Market Cap $185M
- Description
- VYNE Therapeutics Inc., a pharmaceutical company, focuses on developing various therapeutics for the treatment of immuno-inflammatory conditions. The company develops FCD105, a topical combination foam that has completed Phase III clinical trials for the treatment of moderate-to-severe acne vulgaris; and FMX114, a combination of tofacitinib, whi...